Exchange & Returns Information
Review Details
(0)
| Generic For | VALETTE |
|---|---|
| Active Ingredient | ETHINYL ESTRADIOL|DESOGESTREL |
| Strength | 0.02MG|0.15MG |
| Manufacturer | OTSIRA GENETICA |
| Pack Size | Price Per Unit | Unit Price | QTY | CART | Best Coupon Price MAX DISCOUNT |
|---|---|---|---|---|---|
| 2 BOXES - 42 TABLETS | $ 0.83 | $ 34.86 |
$ 29.63
Apply ZARVY26 (-15%)
You save $ 5.23
|
||
| 3 BOXES - 63 TABLETS | $ 0.78 |
6% $ 52.29
$ 49.14
|
$ 41.77
Apply ZARVY26 (-15%)
You save $ 7.37
|
||
| ★ Best Value 4 BOXES - 84 TABLETS | $ 0.74 |
11% $ 69.72
$ 62.31
|
$ 52.96
Apply ZARVY26 (-15%)
You save $ 9.35
|
Reference information will be available soon.
Intimacy Plus 2 is a low-dose combined oral contraceptive (COC) containing Ethinyl Estradiol 0.02 mg and Desogestrel 0.15 mg. It prevents pregnancy by suppressing ovulation, thickening cervical mucus, and stabilizing the endometrium. With its ultra-low estrogen content and the antiandrogenic profile of Desogestrel, it is particularly well-suited for women sensitive to hormonal fluctuations. Beyond contraception, it provides therapeutic benefits in managing menstrual irregularities, dysmenorrhea, and acne, making it a preferred option for first-time users, adolescents, and those prone to estrogen-related side effects.
PILLS & CONTRACEPTION > Hormonal Contraceptive
Provides effective and consistent prevention of pregnancy while maintaining hormonal balance. Especially suitable for those requiring reliable contraception with minimal side effects.
FEMTECH > Menstrual Control
Alleviates period-related discomforts including cramping, acne, and cycle irregularities. Designed for women seeking lifestyle-oriented hormone management and improved cycle stability.
Ethinyl Estradiol suppresses ovulation and stabilizes the endometrial lining
Desogestrel increases cervical mucus viscosity and suppresses luteinizing hormone, reinforcing contraceptive reliability
Low androgenicity minimizes acne, seborrhea, and weight gain, supporting better tolerability for hormone-sensitive women
Ultra-low estrogen dose (0.02 mg) reduces estrogen-induced adverse effects like nausea, breast tenderness, and water retention
Enhances cycle regularity and reduces dysmenorrhea, aligning with femtech-driven hormone management needs
Indication
Prevention of pregnancy (contraception) in adult and postmenarchal females
Oral Tablet Dosage
1 tablet orally once daily at the same time each day, following the order on the 21-day blister pack
Day 1 Start: Begin on the first day of menstruation
Sunday Start: Begin on the first Sunday after menstruation begins
Maintain strict adherence with ≤24-hour intervals to ensure efficacy
Transdermal Patch Dosage
Apply one patch weekly for 3 consecutive weeks (Weeks 1–3)
No patch in Week 4, then repeat cycle
Initiate patch within 24 hours of menstruation onset
Not recommended in patients with BMI ≥30 kg/m² due to thromboembolism risk and reduced effectiveness
Use caution in patients with BMI 25–30 kg/m²
Special Considerations
Monitor for mood changes, breast discomfort, or breakthrough bleeding during the initial adjustment period
Common: Mild nausea, breast tenderness, spotting between periods, headaches
Occasional: Mood swings, weight fluctuation, breakthrough bleeding during initial cycles
Rare: Gallbladder issues, hepatic enzyme changes, skin pigmentation changes
Serious: Blood clots (venous thromboembolism), particularly in smokers or women over 35 – immediate medical attention required if chest pain, shortness of breath, or leg swelling occur
Special Notes: Desogestrel’s low androgenic activity reduces acne and weight gain compared to older progestins
Monitoring Advice: Long-term users should undergo routine blood pressure checks and periodic clinical review
No reviews yet. Be the first to review this product!
No combo deals available at the moment.
